The vaccine advisory committee of the Centers for Disease Control and Prevention is scheduled to meet Dec. 4 and 5. On the agenda: the hepatitis B vaccine, the overall childhood vaccine schedule and specific vaccine ingredients.

This essay examines how recent political intervention has reshaped the CDC’s public messaging on vaccines and autism. In Part 1, I explain why the scientific evidence on this topic has not changed—and why the CDC’s newly revised webpage represents a step backward for public health communication.

A group of local health leaders from across the country said they're worried about how an upcoming meeting could affect immunization access and rates. The meeting could mean changes to more federal vaccine recommendations for serious viruses — like hepatitis B.

The Advisory Committee on Immunization Practices (ACIP) at the Centers for Disease Control and Prevention (CDC) is meeting today and Friday to discuss and vote on the hepatitis B vaccine and to consider sweeping changes to the childhood/adolescent immunization schedule,

The CDC's vaccine advisory committee is expected to stop recommending universal vaccination of newborns against hepatitis B and question the childhood vaccination schedule when they meet Thursday.

The Centers for Disease Control and Prevention’s Advisory Committee on Immunization Practices (ACIP) convenes Thursday and Friday for a closely watched meeting to rethink fundamental elements of the childhood vaccination schedule, which has protected children from dangerous diseases for decades.

Trump is targeting Somalis with racist remarks ahead of expected immigration enforcement activity in Minnesota. And, a CDC advisory panel will revisit long-standing vaccine recommendations.